Mirabegron Extended Release (ER) 25 mg is a medication prescribed for the treatment of overactive bladder (OAB) [1]. It is formulated as an extended-release tablet designed to release the active ingredient gradually over time [2].
How does Mirabegron ER 25 mg work?
Mirabegron ER functions by relaxing the detrusor muscle in the bladder wall [3]. This muscle is responsible for bladder contractions. By relaxing it, mirabegron increases the bladder's capacity to store urine and reduces the involuntary contractions that cause OAB symptoms like urinary urgency, frequency, and urge incontinence [4].
What are the uses for Mirabegron ER 25 mg?
Mirabegron ER 25 mg is indicated for the treatment of symptoms associated with overactive bladder (OAB), which include urinary urgency, increased urinary frequency, and urge incontinence [1][4].
When can generic Mirabegron ER 25 mg be available?
The availability of generic versions of Mirabegron ER depends on patent expirations and regulatory approvals. Information on specific patent statuses and potential generic entry dates can be found through resources that track drug patents [5].
What is the difference between Mirabegron ER 25 mg and 50 mg?
The primary difference between Mirabegron ER 25 mg and 50 mg is the dosage strength. The 25 mg dosage is typically the starting dose and is used for patients who may not need the full 50 mg strength or as an initial step in treatment. The 50 mg dosage provides a higher concentration of the active ingredient and may be used for patients who require a stronger effect or who have not achieved adequate symptom control with the 25 mg dose [4]. The choice between these dosages is determined by a healthcare provider based on individual patient response and tolerability.
What are the potential side effects of Mirabegron ER?
Common side effects associated with Mirabegron ER can include hypertension (high blood pressure), nasopharyngitis (common cold symptoms), and urinary tract infections [4]. Less common side effects may also occur. It is important for patients to discuss any concerns about side effects with their doctor.
Where can I find more information on Mirabegron patents?
DrugPatentWatch.com provides detailed information on drug patents, including those for mirabegron. This resource can help identify patent expiry dates, patent challenges, and related intellectual property information [5].
*
**Sources
1. https://www.rxlist.com/mirabegron-drug.htm
2. https://www.drugs.com/mtm/mirabegron-extended-release.html
3. https://www.nhs.uk/medicines/mirabegron/
4. https://www.mayoclinic.org/drugs-supplements/mirabegron-oral-route/proper-use/drg-20075804
5. https://drugpatentwatch.com/